AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MIFEPRISTONE

10 registrations across 4 African markets— 8 active

Markets with MIFEPRISTONE

Recent registrations

Brand / ProductMarketHolderStatusExpires
GENEFYM🇿🇦South AfricaMedi Challenge (Pty) LtdsuspendedApr 2022
MIFEGYNE
Comprimé / 200 mg
🇹🇳TunisiaEXELGYNexpiredNov 2000
PRESTOGYNE🇿🇦South AfricaMSQ Pharma (Pty) LtdactiveJan 1900
MIFEGYNE 200 mg🇿🇦South AfricaMedi Challenge (Pty) LtdactiveJan 1900
Mifepristone🌍WWQinhuangdao Zizhu Pharmaceutical Co Ltdactive
Mifepristone Tablet 200mg
Tablet
🌍WWLinepharma International Ltdactive
Mifepristone
Film Coated Tablet
🇹🇿TanzaniaChina Resources Zizhu Pharmaceutical Co, Ltdactive
Mifepristone Tablet 200mg
Tablet
🌍WWChina Resources Zizhu Pharmaceutical Co Ltdactive
Mifepristone Tablet + Misoprostol Tablet 200mg + 200mcg
Tablet + Tablet
🌍WWChina Resources Zizhu Pharmaceutical Co Ltdactive
Mifepristone🌍WWQinhuangdao Zizhu Pharmaceutical Co Ltdactive

MIFEPRISTONE in Africa — Regulatory Overview

MIFEPRISTONE is registered across 4 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including WW, South Africa, Tunisia, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 8 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.